|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
1 Hannah Research Institute, Ayr KA6 5HL, UK
2 Roslin Institute, Roslin, Midlothian EH25 9PS, UK
*Author for correspondence (e-mail: flintd{at}hri.sari.ac.uk)
Accepted 27 June 2002
We have previously demonstrated that IGFBP-5 production by mammary epithelial cells increases dramatically during involution of the mammary gland. To demonstrate a causal relationship between IGFBP-5 and cell death we created transgenic mice expressing IGFBP-5 in the mammary gland using a mammary-specific promoter, ß-lactoglobulin. DNA content in the mammary glands of transgenic mice was decreased as early as day 10 of pregnancy. Histological analysis indicated reduced numbers of alveolar end buds, with decreased ductal branching. Transgenic dams produced IGFBP-5 in their milk at concentrations similar to those achieved at the end of normal lactation. Mammary cell number and milk synthesis were both decreased by approximately 50% during the first 10 days of lactation. BrdU labelling was decreased, whereas DNA ladders were increased in transgenic animals on day 1 of lactation. On day 2 postpartum, the epithelial invasion of the mammary fat pad was clearly impaired in transgenic animals. The concentrations of the pro-apoptotic molecule caspase-3 and of plasmin were both increased in transgenic animals whilst the concentrations of 2 prosurvival molecules Bcl-2 and Bcl-xLwere both decreased. In order to examine whether IGFBP-5 acts by inhibiting the survival effect of IGF-I we examined IGF receptor phosphorylation and Akt phosphorylation and showed that both were inhibited. We attempted to "rescue" the transgenic phenotype by using growth hormone to increase endogenous IGF-I concentrations or by implanting minipumps delivering an IGF-1 analogue, R3-IGF-1, which binds weakly to IGFBP-5. Growth hormone treatment failed to affect mammary development suggesting that increased concentrations of endogenous IGF-1 are insufficient to overcome the high concentrations of IGFBP-5 produced by these transgenic animals. In contrast mammary development (gland weight and DNA content) was normalised by R3-IGF-I although milk production was only partially restored. This is the first demonstration that over-expression of IGFBP-5 can lead to; impaired mammary development, increased expression of the pro-apoptotic molecule caspase-3, increased plasmin generation and decreased expression of pro-survival molecules of the Bcl-2 family. It clearly demonstrates that IGF-I is an important developmental/survival factor for the mammary gland and, furthermore, this cell death programme may be utilised in a wide variety of tissues.
Key words: IGFBP-5, Mammary gland, Involution, Apoptosis, Transgenic, Caspase, Plasmin, Mouse
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  C. J. Watson Immune cell regulators in mouse mammary development and involution J Anim Sci, April 1, 2009; 87(13_suppl): 35 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Kleinberg, T. L. Wood, P. A. Furth, and A. V. Lee Growth Hormone and Insulin-Like Growth Factor-I in the Transition from Normal Mammary Development to Preneoplastic Mammary Lesions Endocr. Rev., February 1, 2009; 30(1): 51 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J Allan, J. Beattie, and D. J Flint Epithelial injury induces an innate repair mechanism linked to cellular senescence and fibrosis involving IGF-binding protein-5 J. Endocrinol., November 1, 2008; 199(2): 155 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M Fleming, J. A Brandimarto, and W. S Cohick The mitogen-activated protein kinase pathway tonically inhibits both basal and IGF-I-stimulated IGF-binding protein-5 production in mammary epithelial cells J. Endocrinol., August 1, 2007; 194(2): 349 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ning, B. Hoang, A. G. P. Schuller, T. P. Cominski, M.-S. Hsu, T. L. Wood, and J. E. Pintar Delayed Mammary Gland Involution in Mice with Mutation of the Insulin-Like Growth Factor Binding Protein 5 Gene Endocrinology, May 1, 2007; 148(5): 2138 - 2147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Sun, K. Boyd, W. Xu, J. Ma, C. W. Jackson, A. Fu, J. M. Shillingford, G. W. Robinson, L. Hennighausen, J. K. Hitzler, et al. Acute Myeloid Leukemia-Associated Mkl1 (Mrtf-a) Is a Key Regulator of Mammary Gland Function Mol. Cell. Biol., August 1, 2006; 26(15): 5809 - 5826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D J Flint, M Boutinaud, C B A Whitelaw, G J Allan, and A F Kolb Prolactin inhibits cell loss and decreases matrix metalloproteinase expression in the involuting mouse mammary gland but fails to prevent cell loss in the mammary glands of mice expressing IGFBP-5 as a mammary transgene. J. Mol. Endocrinol., June 1, 2006; 36(3): 435 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhao, P. Yin, L. A. Bach, and C. Duan Several Acidic Amino Acids in the N-domain of Insulin-like Growth Factor-binding Protein-5 Are Important for Its Transactivation Activity J. Biol. Chem., May 19, 2006; 281(20): 14184 - 14191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Sorrell, J. H. Shand, E. Tonner, M. Gamberoni, P. A. Accorsi, J. Beattie, G. J. Allan, and D. J. Flint Insulin-like Growth Factor-binding Protein-5 Activates Plasminogen by Interaction with Tissue Plasminogen Activator, Independently of Its Ability to Bind to Plasminogen Activator Inhibitor-1, Insulin-like Growth Factor-I, or Heparin J. Biol. Chem., April 21, 2006; 281(16): 10883 - 10889. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Ruan, F. Fahlbusch, D. R. Clemmons, M. E. Monaco, P. D. Walden, A. P. Silva, H. A. Schmid, and D. L. Kleinberg SOM230 Inhibits Insulin-Like Growth Factor-I Action in Mammary Gland Development by Pituitary Independent Mechanism: Mediated through Somatostatin Subtype Receptor 3? Mol. Endocrinol., February 1, 2006; 20(2): 426 - 436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Hadsell, D. T. Torres, N. A. Lawrence, J. George, A. F. Parlow, A. V. Lee, and M. L. Fiorotto Overexpression of Des(1-3) Insulin-Like Growth Factor 1 in the Mammary Glands of Transgenic Mice Delays the Loss of Milk Production with Prolonged Lactation Biol Reprod, December 1, 2005; 73(6): 1116 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Flint, M. T. Travers, M. C. Barber, N. Binart, and P. A. Kelly Diet-induced obesity impairs mammary development and lactogenesis in murine mammary gland Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1179 - E1187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Yin, Q. Xu, and C. Duan Paradoxical Actions of Endogenous and Exogenous Insulin-like Growth Factor-binding Protein-5 Revealed by RNA Interference Analysis J. Biol. Chem., July 30, 2004; 279(31): 32660 - 32666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bagheri-Yarmand, A. H. Talukder, R.-A. Wang, R. K. Vadlamudi, and R. Kumar Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis Development, July 15, 2004; 131(14): 3469 - 3479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Green, M. J. Naylor, E. T. Lowe, P. Wang, E. Marshman, and C. H. Streuli Caspase-mediated Cleavage of Insulin Receptor Substrate J. Biol. Chem., June 11, 2004; 279(24): 25149 - 25156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Allar and T. L. Wood Expression of the Insulin-Like Growth Factor Binding Proteins during Postnatal Development of the Murine Mammary Gland Endocrinology, May 1, 2004; 145(5): 2467 - 2477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Suchyta, S. Sipkovsky, R. G. Halgren, R. Kruska, M. Elftman, M. Weber-Nielsen, M. J. Vandehaar, L. Xiao, R. J. Tempelman, and P. M. Coussens Bovine mammary gene expression profiling using a cDNA microarray enhanced for mammary-specific transcripts Physiol Genomics, December 16, 2003; 16(1): 8 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Jager, U. Werling, S. Rimpf, A. Jacob, and H. Schorle Transcription Factor AP-2{gamma} Stimulates Proliferation and Apoptosis and Impairs Differentiation in a Transgenic Model Mol. Cancer Res., October 1, 2003; 1(12): 921 - 929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Butt, K. A. Dickson, F. McDougall, and R. C. Baxter Insulin-like Growth Factor-binding Protein-5 Inhibits the Growth of Human Breast Cancer Cells in Vitro and in Vivo J. Biol. Chem., August 8, 2003; 278(32): 29676 - 29685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Naylor, E. Ginsburg, T. P. Iismaa, B. K. Vonderhaar, D. Wynick, and C. J. Ormandy The Neuropeptide Galanin Augments Lobuloalveolar Development J. Biol. Chem., August 1, 2003; 278(31): 29145 - 29152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bagheri-Yarmand, R. K. Vadlamudi, and R. Kumar Activating Transcription Factor 4 Overexpression Inhibits Proliferation and Differentiation of Mammary Epithelium Resulting in Impaired Lactation and Accelerated Involution J. Biol. Chem., May 2, 2003; 278(19): 17421 - 17429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Marshman, K. A. Green, D. J. Flint, A. White, C. H. Streuli, and M. Westwood Insulin-like growth factor binding protein 5 and apoptosis in mammary epithelial cells J. Cell Sci., February 15, 2003; 116(4): 675 - 682. [Abstract] [Full Text] [PDF]
|
|
